|
|
Volumn 18, Issue 16, 2010, Pages 5981-5987
|
|
Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N′-substituted-2,6-piperidinedione
a
a
a
a
a
a
a
a
a
|
|
Author keywords
3 phenylalanyl N substituted 2,6 piperidinedione derivates; Aminopeptidase N inhibitors; Structure based drug design
|
|
Indexed keywords
(2) 2 AMINO N (1 (2 (2 (HYDROXYAMINO) 2 OXOETHYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
(2) 2 AMINO N (1 (2 (2 FLUOROPHENYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
(2) 2 AMINO N (1 (2 (2,4 DIMETHYLPHENYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
(2) 2 AMINO N (1 (2 (3 CHLORO 4 FLUOROPHENYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
(2) 2 AMINO N (1 (2 (3 CHLOROPHENYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
(2) 2 AMINO N (1 (2 (3,4 DIFLUOROPHENYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
(2) 2 AMINO N (1 (2 (4 BROMOPHENYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
(2) 2 AMINO N (1 (2 (4 METHOXYPHENYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACET AMIDO) 4 METHYLPENTANOIC ACID;
2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO) 3 METHYLBUTANOIC ACID;
2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO) 3 PHENYLPROPANOIC ACID;
2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO)ACETIC ACID;
2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO)PENTANEDIOIC ACID;
2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO)PROPANOIC ACID;
2 AMINO N (1 (2 (4 FLUOROPHENYLAMINO) 2 OXOETHYL) 2,6 DIOXOPIPERIDIN 3 YL) 3 PHENYLPROPANAMIDE;
3 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO)PROPANOIC ACID;
ANTINEOPLASTIC AGENT;
BENZYL 2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL) ACETAMIDO) 3 METHYLBUTANOATE;
BENZYL 2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL) ACETAMIDO)PROPANOATE;
BENZYL 2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL))ACETATE;
BENZYL 2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO) 3 PHENYLPROPANOATE;
BENZYL 2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO) 4 METHYLPENTANOATE;
BENZYL 3 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO)PROPANOATE;
BESTATIN;
DIBENZYL 2 (2 (3 (2 AMINO 3 PHENYLPROPANAMIDO) 2,6 DIOXOPIPERIDIN 1 YL)ACETAMIDO)PENTANEDIOATE;
MICROSOMAL AMINOPEPTIDASE;
UNCLASSIFIED DRUG;
ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG POTENCY;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IC 50;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ANTIGENS, CD13;
ANTINEOPLASTIC AGENTS;
CELL PROLIFERATION;
HL-60 CELLS;
HUMANS;
INHIBITORY CONCENTRATION 50;
MOLECULAR STRUCTURE;
NEOPLASMS;
PHENYLALANINE;
PIPERIDONES;
PROTEASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
SWINE;
|
|
EID: 77955473389
PISSN: 09680896
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmc.2010.06.078 Document Type: Article |
|
Times cited : (10)
|
|
References (20)
|
